$NVAX News

Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold

Assessing Novavax (NVAX) Valuation As Trading Swings Revive Investor Interest

3 Small-Cap Stocks That Fall Short

Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Why Novavax (NVAX) Stock Is Trading Up Today

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax: Betting On This Vaccine Maker's Turnaround Story, After Pfizer Deal

Novavax Stock Is Red Hot but the Smart Money Is Slamming on the Brakes

Novavax, Inc. 2026 Q1 - Results - Earnings Call Presentation

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax (NVAX) Q3 2025 Earnings Transcript

Novavax (NVAX) Q1 2026 Earnings Transcript

Novavax (NVAX) Q2 2025 Earnings Transcript

TD Cowen Maintains Hold on Novavax, Raises Price Target to $9

Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

Novavax Q1 2026 Earnings Call Transcript

Novavax Affirms FY2026 Sales Guidance of $230.000M-$270.000M vs $393.277M Est

Novavax Q1 EPS $(0.06), Sales $139.514M Beat $78.323M Estimate

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?